- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostatic Hyperplasia in New Zealand
Total 1406 results
-
Heinrich-Heine University, DuesseldorfUnknown
-
Thomas Jefferson UniversityProstate Cancer FoundationActive, not recruitingBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8United States
-
University of RochesterVarian Medical SystemsRecruitingRecurrent Prostate Cancer After SurgeryUnited States
-
AstraZenecaParexelCompleted
-
Weill Medical College of Cornell UniversityRecruitingProstate CancerUnited States
-
Weill Medical College of Cornell UniversityActive, not recruiting
-
Icahn School of Medicine at Mount SinaiActive, not recruiting
-
Icahn School of Medicine at Mount SinaiSanofi; BayerCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAragon Pharmaceuticals, Inc.Completed
-
Ascenta TherapeuticsCompletedProstate CancerUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Hormone-refractory Prostate CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedProstate Cancer | Precancerous/Nonmalignant ConditionUnited States
-
ExelixisTerminatedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States, Canada, Australia, United Kingdom, Ireland
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
Duke UniversityJohns Hopkins University; Memorial Sloan Kettering Cancer Center; University... and other collaboratorsCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
NYU Langone HealthCompletedAtypical Endometrial Hyperplasia | Endometrial CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedProstate CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Candel Therapeutics, Inc.Active, not recruitingProstate CancerUnited States, Puerto Rico
-
AstraZenecaCompletedNon-metastatic Prostate CancerUnited States, Canada
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
AstraZenecaCompletedProstate CancerUnited Kingdom, Germany, United States
-
Memorial Sloan Kettering Cancer CenterFerring PharmaceuticalsActive, not recruitingMetastatic Castration Sensitive Prostate CancerUnited States
-
Weill Medical College of Cornell UniversityTerminatedQuality of Life | Prostate CancerUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
American Medical SystemsCompleted
-
Cougar Biotechnology, Inc.CompletedProstatic Neoplasms | Prostate CancerUnited States, United Kingdom
-
Janssen Research & Development, LLCCompletedProstate NeoplasmsUnited States, Canada
-
State University of New York at BuffaloRecruitingProstate CancerUnited States
-
Yale UniversityPfizerRecruiting
-
Weill Medical College of Cornell UniversityRecruiting
-
Hackensack Meridian HealthUppsala University, Sweden (Department of Immunology, Genetics and Pathology)Suspended
-
Weill Medical College of Cornell UniversityPOINT BiopharmaSuspendedProstate CancerUnited States
-
Martin GutierrezNovartisWithdrawnProstate CancerUnited States
-
BHR Pharma, LLCQ2 Solutions; H2O Clinical LLCTerminatedCancer of the ProstateUnited States
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
GlaxoSmithKlineCompletedNeoplasmsUnited States, United Kingdom
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Head and Neck Cancer | Prostate CancerUnited States
-
AgennixCompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States, United Kingdom, France, Italy, Israel, Germany, Hungary, Argentina, Russian Federation, Belgium, Croatia, Netherlands, Peru, Poland, Spain
-
Weill Medical College of Cornell UniversityRecruiting
-
Yale UniversityRecruitingProstate CancerUnited States
-
University of New MexicoWithdrawn
-
Roswell Park Cancer InstituteCompleted
-
Barr LaboratoriesCompletedHot Flashes | Prostate CancerUnited States
-
SanofiCompletedProstate CancerUnited States
-
RPCR, Inc.UnknownProstate Cancer Early Risk Treated by Radiosurgery | Prostate Cancer Intermediate Risk Treated by RadiosurgeryUnited States
-
Cortice Biosciences, Inc.TerminatedProstate CancerUnited States